This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Protein and lipid kinase inhibitors as targeted anticancer agents of the Ras/Raf/MEK and PI3K/PKB pathways
Purinergic Signalling Open Access 04 June 2008
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Yang, O. O. et al. J. Virol. 71, 3120– 3128 (1997).
Allen, T. M. et al. Nature 407, 386–390 (2000).
Goulder, P. J. R. et al. AIDS 13 (suppl. A), S121–S136 (1999).
Goulder, P. J. R. et al. Nature Med. 3, 212– 217 (1997).
Borrow, P. et al. Nature Med. 3, 205–211 (1997).
Price, D. A. et al. Proc. Natl Acad. Sci. USA 94, 1890– 1895 (1997).
Brander, C. et al. J. Clin. Invest. 101, 2559– 2566 (1998).
Pantaleo, G. et al. Proc. Natl Acad. Sci. USA 94, 254– 258 (1997).
Lyles, R. H. et al. J. Infect. Dis. 181, 872– 880 (2000).
Cafaro, A. et al. Nature Med. 5, 643– 650 (1999).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Walker, B., Goulder, P. Escape from the immune system. Nature 407, 313–314 (2000). https://doi.org/10.1038/35030283
Issue Date:
DOI: https://doi.org/10.1038/35030283
This article is cited by
-
Protein and lipid kinase inhibitors as targeted anticancer agents of the Ras/Raf/MEK and PI3K/PKB pathways
Purinergic Signalling (2009)